Cargando…

Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients

Testicular germ-cell tumors (TGCT) have been widely recognized for their outstanding survival rates, commonly attributed to their high sensitivity to cisplatin-based therapies. Despite this, a subset of patients develops cisplatin resistance, for whom additional therapeutic options are unsuccessful,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuevas-Estrada, Berenice, Montalvo-Casimiro, Michel, Munguia-Garza, Paulina, Ríos-Rodríguez, Juan Alberto, González-Barrios, Rodrigo, Herrera, Luis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178517/ https://www.ncbi.nlm.nih.gov/pubmed/37175579 http://dx.doi.org/10.3390/ijms24097873

Ejemplares similares

Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families
por: McMaster, Mary L, et al.
Publicado: (2015)

Evaluation of chemoresponse assays as predictive markers
por: Korn, E L, et al.
Publicado: (2015)

In Search of TGCT Biomarkers: A Comprehensive In Silico and Histopathological Analysis
por: Raos, Dora, et al.
Publicado: (2020)

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
por: Tap, William D., et al.
Publicado: (2022)

Overview of a chemoresponse assay in ovarian cancer
por: Grendys, E. C., et al.
Publicado: (2014)

In vitro chemoresponse in metachronous pairs of gyneclologic cancers
por: Dalton, Heather J, et al.
Publicado: (2014)

Comment on: ‘Evaluation of chemoresponse assays as predictive markers'
por: Tian, C, et al.
Publicado: (2015)

The utility of cfDNA in TGCT patient management: a systematic review
por: Krasic, Jure, et al.
Publicado: (2022)

Electrochemical Fine-Tuning of the Chemoresponsiveness of Langmuir–Blodgett Graphene Oxide Films
por: Devida, Juan M., et al.
Publicado: (2023)

Erratum to “The utility of cfDNA in TGCT patient management: a systematic review”
Publicado: (2022)

Response to Comment on: ‘Evaluation of chemoresponse assays as predictive biomarkers'
por: Korn, E L, et al.
Publicado: (2015)

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer
por: Matondo, Abel, et al.
Publicado: (2017)

National Meeting Breaks the Mold
por: Wakefield, Julie
Publicado: (2004)

Chemical Sensing and Chemoresponsive Pumping with Conical-Pore Polymeric Membranes
por: Bush, Stevie N., et al.
Publicado: (2020)

Break the Mold: A Ten-Year Evolution of Ear Molding Techniques
por: Charipova, Karina, et al.
Publicado: (2020)

Identification of mRNA Prognostic Markers for TGCT by Integration of Co-Expression and CeRNA Network
por: Zhu, Fang, et al.
Publicado: (2021)

Expression of Heat Shock Protein 70 Modulates the Chemoresponsiveness of Pancreatic Cancer
por: Hyun, Jong Jin, et al.
Publicado: (2013)

miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor Blastema
por: Watson, Jenny A., et al.
Publicado: (2013)

Chemoresponse after non-curative gastrectomy for M1 gastric cancer
por: Shin, Hyun Beak, et al.
Publicado: (2015)

Design of Chemoresponsive Soft Matter Using Hydrogen-Bonded Liquid Crystals
por: Yu, Huaizhe, et al.
Publicado: (2021)

Breaking the Mold: New Strategies for Fighting Aflatoxins
por: Schmidt, Charles W.
Publicado: (2013)

Towards first-principles molecular design of liquid crystal-based chemoresponsive systems
por: Roling, Luke T., et al.
Publicado: (2016)

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis
por: Davidson, Brittany A., et al.
Publicado: (2016)

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
por: Gutekunst, Matthias, et al.
Publicado: (2011)

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
por: Bernthal, Nicholas M., et al.
Publicado: (2021)

Breaking the mold: chefs-d'oeuvre de moisissure
por: Collective
Publicado: (2018)

Erratum: “Breaking the Mold: New Strategies for Fighting Aflatoxins”
Publicado: (2014)

An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer
por: Shahid, Muhammad, et al.
Publicado: (2016)

Relation between mismatch repair status, chemoresponse, survival and anatomic location in gastroesophageal adenocarcinoma
por: Evaristo, Gertruda, et al.
Publicado: (2023)

The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2023)

Surgical management of 144 diffuse‐type TGCT patients in a single institution: A 20‐year cohort study
por: Spierenburg, Geert, et al.
Publicado: (2022)

Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction
por: Wan, Ying-Wooi, et al.
Publicado: (2010)

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
por: Al Amri, Waleed S., et al.
Publicado: (2020)

MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer
por: Baxter, Diana E., et al.
Publicado: (2021)

Breaking the Leadership Mold: An Executive's Guide to Achieving Organizational Excellence
por: Kuzmeski, Maribeth
Publicado: (2010)

Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
por: Huggins, Jonathan, et al.
Publicado: (2018)

Dataset of testicular germ cell tumors (TGCT) risk associated with serum polychlorinated biphenyl (PCB) by age at diagnosis and histologic types
por: Cheng, Zhiyuan, et al.
Publicado: (2021)

Genomic Profile in a Non-Seminoma Testicular Germ-Cell Tumor Cohort Reveals a Potential Biomarker of Sensitivity to Platinum-Based Therapy
por: González-Barrios, Rodrigo, et al.
Publicado: (2022)

Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness
por: Thakur, Archana, et al.
Publicado: (2021)

Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle—A systematic review and meta-analysis
por: Siegel, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6pdqa55ekg91us5lbqphqu8lsm